
FDA Expands Pilot Program for Digital Mental Health Tools
Two new companies, Sondermind and Limbic, have joined a key FDA pilot program aimed at evaluating digital health devices for treating anxiety and depression, signaling a major step forward for regulated digital therapeutics.











